Literature DB >> 25913640

Impact of pharmacist intervention on antibiotic use and prophylactic antibiotic use in urology clean operations.

Y Zhou1, L-Y Ma1, X Zhao1, S-H Tian1, L-Y Sun1, Y-M Cui1.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: The use of prophylactic antibiotics in clean operations was routine in China before 2011. Along with the appeal for using antibiotics rationally by WHO in 2011, China launched a national special rectification scheme on clinical use of antibiotics from April that year. The scheme, aimed at achieving rational use of antibiotics, made pharmacists part of the responsible medical team. Our objective was to describe the impacts of pharmacist intervention on the use of antibiotics, particularly in urology clean operations.
METHODS: Pharmacists participated in antibiotic stewardship programmes of the hospital and urological clinical work and conducted real-time interventions at the same time from 2011 to 2013. Data on the use of antibiotics between 2010 and 2013 in urology were collected.
RESULTS: Comparison of the 2013 data with those of 2010 showed that antibiotic use density [AUD= DDDs*100/(The number of patients who were treated the same period*Average days in hospital). DDDs = Total drug consumption (g)/DDD. DDD is the Defined Daily Dose] decreased by 57·8(58·8%); average antibiotic cost decreased by 246·94 dollars; the cost of antibiotics as a percentage of total drug cost decreased by 27·7%; the rate of use of antibiotics decreased from 100% to 7·3%. WHAT IS NEW AND
CONCLUSION: The study illustrates how an antibiotic stewardship programme with pharmacist participation including real-time interventions can promote improved antibiotic-prescribing and significantly decrease costs.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  China; antibiotics; clean operation; pharmacist intervention; urology

Mesh:

Substances:

Year:  2015        PMID: 25913640     DOI: 10.1111/jcpt.12275

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  23 in total

1.  [Nationwide survey among institutes of microbiology in academic medicine : Is the interdisciplinary approach the right way to treat patients with urogenital infections?]

Authors:  L Schneidewind; J Kranz; D Schlager; A E Pelzer
Journal:  Urologe A       Date:  2017-06       Impact factor: 0.639

2.  Uncomplicated Bacterial Community-Acquired Urinary Tract Infection in Adults.

Authors:  Jennifer Kranz; Stefanie Schmidt; Cordula Lebert; Laila Schneidewind; Guido Schmiemann; Florian Wagenlehner
Journal:  Dtsch Arztebl Int       Date:  2017-12-15       Impact factor: 5.594

3.  Efficacy and feasibility of a collaborative multidisciplinary program for antibiotic prophylaxis in clean wound surgery.

Authors:  Xinyu Li; Hong Chen; Shenyin Zhu; Yu Liu; Jiadan Yang; Zhe Yuan; Gaoqun Yao; Feng Qiu
Journal:  Int J Clin Pharm       Date:  2017-12-12

4.  Impact of 'Chief-Pharmacist System' on drug expenditures and rational drug use.

Authors:  Zhuo Ma; ZhiXia Zhao; ShuSen Sun; YiFan Li; ZhuoLing An; Yan Yan; LiHong Liu
Journal:  Int J Clin Pharm       Date:  2020-01-09

Review 5.  Evidence of clinical and economic impact of pharmacist interventions related to antimicrobials in the hospital setting.

Authors:  L Leache; I Aquerreta; A Aldaz; A Idoate; A Ortega
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-10       Impact factor: 3.267

Review 6.  [Epidemiology, diagnostics, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients : Update 2017 of the interdisciplinary AWMF S3 guideline].

Authors:  J Kranz; S Schmidt; C Lebert; L Schneidewind; W Vahlensieck; U Sester; R Fünfstück; S Helbig; W Hofmann; E Hummers; M Kunze; E Kniehl; K Naber; F Mandraka; B Mündner-Hensen; G Schmiemann; F M E Wagenlehner
Journal:  Urologe A       Date:  2017-06       Impact factor: 0.639

7.  Peking University Health Science Center Model of Clinical Pharmacy Education and Clinical Pharmacist Services.

Authors:  Zi-Hao Chen; Yi-Min Cui; Ying Zhou; Zi-Ning Wang; Yang Ke
Journal:  Chin Med J (Engl)       Date:  2016-12-05       Impact factor: 2.628

8.  Effectiveness of continuous improvement by a clinical pharmacist-led guidance team on the prophylactic antibiotics usage rationality in intervention procedure at a Chinese tertiary teaching hospital.

Authors:  Ping Yang; Sai-Ping Jiang; Xiao-Yang Lu
Journal:  Ther Clin Risk Manag       Date:  2017-04-11       Impact factor: 2.423

9.  Optimizing Prophylactic Antibiotic Practice for Cardiothoracic Surgery by Pharmacists' Effects.

Authors:  Ling Zhou; Jingjing Ma; Jie Gao; Shiqi Chen; Jianan Bao
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 10.  Enhancing pharmacists' role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review.

Authors:  M H F Sakeena; Alexandra A Bennett; Andrew J McLachlan
Journal:  Antimicrob Resist Infect Control       Date:  2018-05-02       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.